EDESA BIOTECH, INC. Increase (Decrease) in Prepaid Expense and Other Assets
EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $145.11 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $25.31K, a 650.68% increase year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$36.12K.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $155.92K.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$34.48K.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$107.83K.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$197.14K.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$301.50K, a 1646.41% decline from fiscal 2022.
- EDESA BIOTECH, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $19.50K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $25.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | -$10.81K derived: sum of 2 quarters · filed 2026-08-13 | $145.11K 10-Q · filed 2026-08-13 | $110.63K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$36.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $119.80K 10-Q · filed 2026-05-14 | $85.32K derived: sum of 3 quarters · filed 2026-05-14 | $88.69K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $155.92K 10-Q · filed 2026-02-13 | $121.44K derived: sum of 2 quarters · filed 2026-02-13 | $124.82K derived: sum of 3 quarters · filed 2026-08-13 | $91.73K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$34.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | -$31.11K derived: sum of 2 quarters · filed 2026-08-13 | -$64.20K derived: sum of 3 quarters · filed 2026-08-13 | -$107.83K 10-K · filed 2025-12-12 | |
| 2025-06-30 | $3.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | -$29.72K derived: sum of 2 quarters · filed 2026-08-13 | -$73.36K 10-Q · filed 2026-08-13 | -$160.84K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$33.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | -$76.73K 10-Q · filed 2026-05-14 | -$164.22K derived: sum of 3 quarters · filed 2026-05-14 | -$35.90K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$43.64K 10-Q · filed 2026-02-13 | -$131.13K derived: sum of 2 quarters · filed 2026-02-13 | -$2.81K derived: sum of 3 quarters · filed 2026-02-13 | -$202.11K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | -$87.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $40.83K derived: sum of 2 quarters · filed 2025-12-12 | -$158.47K derived: sum of 3 quarters · filed 2025-12-12 | -$197.14K 10-K · filed 2025-12-12 | |
| 2024-06-30 | $128.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | -$70.98K derived: sum of 2 quarters · filed 2025-08-08 | -$109.65K 10-Q · filed 2025-08-08 | -$72.12K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$199.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$237.97K 10-Q · filed 2025-05-14 | -$200.44K derived: sum of 3 quarters · filed 2025-05-14 | -$398.62K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$38.66K 10-Q · filed 2025-02-14 | $38.66K 10-Q · filed 2024-02-09 | -$1.14K derived: sum of 2 quarters · filed 2025-02-14 | -$199.32K derived: sum of 3 quarters · filed 2025-02-14 | -$397.89K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $37.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | -$160.65K derived: sum of 2 quarters · filed 2024-12-13 | -$359.23K derived: sum of 3 quarters · filed 2024-12-13 | -$301.50K 10-K · filed 2024-12-13 | |
| 2023-06-30 | -$198.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$396.75K derived: sum of 2 quarters · filed 2024-08-09 | -$339.03K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$198.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | -$140.85K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $57.72K 10-Q · filed 2024-02-09 | ||||
| 2022-09-30 | $19.50K 10-K · filed 2023-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |